
Hernandezine
CAS No. 6681-13-6
Hernandezine( —— )
Catalog No. M29163 CAS No. 6681-13-6
Hernandezine is an activator of AMPK activator and a selective reversing agent for ABCB1-mediated MDR in cancer cells.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 501 | In Stock |
![]() ![]() |
10MG | 707 | In Stock |
![]() ![]() |
25MG | 1107 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameHernandezine
-
NoteResearch use only, not for human use.
-
Brief DescriptionHernandezine is an activator of AMPK activator and a selective reversing agent for ABCB1-mediated MDR in cancer cells.
-
DescriptionHernandezine is an activator of AMPK activator and a selective reversing agent for ABCB1-mediated MDR in cancer cells.(In Vitro):Hernandezine inhibits LPS-induced TNF-α expression/production in human macrophage cell lines (THP-1 and U93). Hernandezine inhibits the transport function of ABCB1, and enhances drug-induced apoptosis in cancer cells. Hernandezine significantly resensitizes ABCB1-overexpressing cancer cells to multiple chemotherapeutic drugs at nontoxic, nanomolar concentrations.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetTNF
-
RecptorTNF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6681-13-6
-
Formula Weight652.788
-
Molecular FormulaC39H44N2O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc2C[C@@H]3N(C)CCc4c(OC)c(OC)c(OC)c(Oc5cc6[C@H](Cc7ccc(Oc1c2)cc7)N(C)CCc6cc5OC)c34
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Certolizumab pegol
Certolizumab pegol (Certolizumab) is a polyethylene glycolated and humanized anti-TNF-α monoclonal antibody for the study of autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).
-
GSK963 (Racemate)
GSK963 (Racemate) a structurally distinct potent and selective inhibitor of RIP1 kinase(IC50=29?nM).
-
Bioymifi
Bioymifi can act as a single agent to induce DR5 clustering and aggregation, leading to apoptosis